Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of PCNA, p53, K-ras and LOH in endocrine pancreas tumors.

Hepato-gastroenterology - 1 Jan 2000

Sato T, Konishi K, Kimura H, Maeda K, Yabushita K, Tsuji M, Miwa A

Abstract excerpt

BACKGROUND/AIMS: The object of this study was to evaluate the characters of the endocrine pancreas tumors including proliferative activity, p53 mutation, K-ras mutation and microsatellite instability. METHODOLOGY: The 13 endocrine tumors of the pancreas were enrolled in this study. There were 8 hypervascular tumors and 4 normo- or hypovascular tumors. All cases were immunohistochemically characterized in paraffin...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Cell Division
Share to Genes, ras

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Loss of Heterozygosity

Share to Microsatellite Repeats

Share to Mutation

Share to Pancreatic Neoplasms

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 10919051

Genes

PCNA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of PCNA, p53, K-ras and LOH in endocrine pancreas tumors.PMID 10919051Read ↗

K-ras mutation in focal proliferative lesions of human pancreas.Semantic proximity Read ↗

Tumor angiogenesis in chronic pancreatitis and pancreatic adenocarcinoma: impact of K-ras mutations.Semantic proximity Read ↗

Comparison of mutations of ras oncogene in human pancreatic exocrine and endocrine tumors.Semantic proximity Read ↗

Ras gene mutations in intraductal papillary neoplasms of the pancreas. Analysis in five cases.Semantic proximity Read ↗

Angiogenesis and p53 and H-ras mutations in pancreatic ductal adenocarcinoma.Semantic proximity Read ↗

K-ras gene mutations and loss of heterozygosity at the p53 gene locus relative to histological characteristics of mucin-producing tumors of the pancreas.Semantic proximity Read ↗

Ki-ras codon 12 point mutation and p53 mutation in pancreatic diseases.Semantic proximity Read ↗

Histone H3 mRNA in situ hybridization for identifying proliferating cells in human pancreas, with special reference to the ductal system.Semantic proximity Read ↗

p53 protein and proliferating cell nuclear antigen in eccrine poroma and porocarcinoma. an immunohistochemical study.Semantic proximity Read ↗

Ki-ras oncogene activation in preinvasive pancreatic cancer.Semantic proximity Read ↗

p53 protein overexpression and K-ras codon 12 mutation in pancreatic ductal carcinoma: correlation with histologic factors.Semantic proximity Read ↗

[Cell kinetics of colorectal tumors with assessment by K-ras mutation and PCNA labeling index].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.